Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Future Medicinal Chemistry|January 21, 2026
Emerging roles of PARP-1 driven dual inhibitors in cancer therapy: SAR-guided strategies and synthetic lethalityRyena Dhir, Pitam Ghosh, Dinki Sharma, et al.Mini Reviews in Medicinal Chemistry|May 15, 2026
Structural Aspects of Coumarin-heterocycle Conjugates: A New Frontier in Antidiabetic Drug DiscoveryDinki Sharma, Pitam Ghosh, Ryena Dhir, et al.Molecular Diversity|May 3, 2026
Integrating AI into next-generation PROTAC Engineering: a comprehensive toolkit for rational PROTAC designPitam Ghosh, Ryena Dhir, Dinki Sharma, et al.RSC Advances|July 22, 2026
AI-driven computational drug design: tools, workflow and challengesRyena Dhir, Pitam Ghosh, Dinki Sharma, et al.Future Medicinal Chemistry|July 11, 2026
LSD1-based dual-target inhibitors as emerging anticancer agents: pharmacological perspectives and SAR explorationPitam Ghosh, Ryena Dhir, Dinki Sharma, et al.Anti-Cancer Agents in Medicinal Chemistry|July 21, 2021
Structural Aspects of mTOR Inhibitors: Search for Potential CompoundsKamalpreet Kaur, Arjun Anant, Vivek AsatiExpert Opinion on Therapeutic Patents|April 30, 2019
An updated patent review of therapeutic applications of chalcone derivatives (2014-present)Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar BhartiEuropean Journal of Medicinal Chemistry|April 8, 2019
PIM kinase inhibitors: Structural and pharmacological perspectivesVivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar BhartiAnti-Cancer Agents in Medicinal Chemistry|June 7, 2016
Mutant B-Raf Kinase Inhibitors as Anticancer AgentsVivek Asati, Sanjay K Bharti, Debarshi K MahapatraEuropean Journal of Medicinal Chemistry|May 26, 2015
Anti-cancer chalcones: Structural and molecular target perspectivesDebarshi Kar Mahapatra, Sanjay Kumar Bharti, Vivek AsatiPageof 7